Literature DB >> 16548955

Urinary catecholamine excretion in tetanus.

C L Thwaites1, L M Yen, S M Cordon, N T Binh, N T, Ngoc Nga, N J White, N Soni, I A MacDonald, J J Farrar.   

Abstract

Imperfect understanding of the pathophysiology of tetanus has limited therapeutic advances. Autonomic disturbance is a major cause of mortality and is believed to be associated with catecholamine release, predominantly norepinephrine. We measured epinephrine and norepinephrine concentrations in 24-h urine collections from tetanus and critically ill patients suffering from other severe diseases. In patients with severe tetanus, mean (SD) epinephrine was 164.18 (129.37) nmol x day(-1) compared with 45.18 (37.74) nmol x day(-1) in mild-moderate disease (p = 0.008). In the severe group, mean (SD) norepinephrine was 411.64 (208.5), and 121.00 (81.81) nmol x day(-1) in moderately ill patients (p < 0.001). Compared with critically ill control patients, median epinephrine was 331.77 in tetanus patients and 89.70 nmol x day(-1) in controls (p < 0.001). Median norepinephrine concentration was 788.02 nmol x day(-1) in tetanus and 300.05 nmol x day(-1) in control patients, p = 0.006. The study finds a novel result of increased epinephrine excretion in tetanus and confirms that catecholamine excretion in tetanus exceeds that in other critically ill patients. These results should be considered in designing more effective therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548955     DOI: 10.1111/j.1365-2044.2006.04580.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

Review 1.  Maternal and neonatal tetanus.

Authors:  C Louise Thwaites; Nicholas J Beeching; Charles R Newton
Journal:  Lancet       Date:  2014-08-19       Impact factor: 79.321

Review 2.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

3.  Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial.

Authors:  Phan Tu Qui; Truong Huu Khanh; Huynh Trung Trieu; Phạm Thanh Giang; Nguyen Ngọc Bich; Le Phan Kim Thoa; Le Nguyen Thanh Nhan; Saraswathy Sabanathan; Rogier Van Doorn; Nguyen Duc Toan; Laura Merson; Nguyen Thi Phuong Dung; Lam Phung Khanh; Marcel Wolbers; Nguyen Thanh Hung; Nguyen Van Vinh Chau; Bridget Wills
Journal:  Trials       Date:  2016-02-19       Impact factor: 2.279

4.  Heart Rate Variability as an Indicator of Autonomic Nervous System Disturbance in Tetanus.

Authors:  Ha Thi Hai Duong; Girmaw Abebe Tadesse; Phung Tran Huy Nhat; Nguyen Van Hao; John Prince; Tran Duc Duong; Trịnh Trung Kien; Le Thanh Hoang Nhat; Le Van Tan; Chris Pugh; Huynh Thi Loan; Nguyen Van Vinh Chau; Lam Minh Yen; Tingting Zhu; David Clifton; Louise Thwaites
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.